Pilot Study of Irreversible Electroporation (IRE) to Treat Early-Stage Primary Liver Cancer (HCC)

NCT01078415 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Hepatocellular

Interventions

DEVICE: Ablation with the NanoKnife Low Energy Direct Current (LEDC) System

Sponsor

Angiodynamics, Inc.